These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 35779943)
1. Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set. Jyani G; Sharma A; Prinja S; Kar SS; Trivedi M; Patro BK; Goyal A; Purba FD; Finch AP; Rajsekar K; Raman S; Stolk E; Kaur M Value Health; 2022 Jul; 25(7):1218-1226. PubMed ID: 35779943 [TBL] [Abstract][Full Text] [Related]
2. Valuing health-related quality of life among the Indian population: a protocol for the Development of an EQ-5D Value set for India using an Extended design (DEVINE) Study. Jyani G; Prinja S; Kar SS; Trivedi M; Patro B; Purba F; Pala S; Raman S; Sharma A; Jain S; Kaur M BMJ Open; 2020 Nov; 10(11):e039517. PubMed ID: 33444194 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of EuroQol Valuation Technology (EQ-VT) Designs to Generate National Value Sets: Learnings from the Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study. Jyani G; Yang Z; Sharma A; Goyal A; Stolk E; Purba FD; Grover S; Kaur M; Prinja S Med Decis Making; 2023 Aug; 43(6):692-703. PubMed ID: 37480281 [TBL] [Abstract][Full Text] [Related]
4. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians. Welie AG; Gebretekle GB; Stolk E; Mukuria C; Krahn MD; Enquoselassie F; Fenta TG Value Health Reg Issues; 2020 Sep; 22():7-14. PubMed ID: 31683254 [TBL] [Abstract][Full Text] [Related]
5. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L. Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267 [TBL] [Abstract][Full Text] [Related]
6. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set. Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730 [TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life among Indian population: The EQ-5D population norms for India. Jyani G; Prinja S; Garg B; Kaur M; Grover S; Sharma A; Goyal A J Glob Health; 2023 Feb; 13():04018. PubMed ID: 36799239 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K Value Health; 2016; 19(5):648-54. PubMed ID: 27565282 [TBL] [Abstract][Full Text] [Related]
9. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments. Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626 [TBL] [Abstract][Full Text] [Related]
10. Valuation of the EQ-5D-5L in Taiwan. Lin HW; Li CI; Lin FJ; Chang JY; Gau CS; Luo N; Pickard AS; Ramos Goñi JM; Tang CH; Hsu CN PLoS One; 2018; 13(12):e0209344. PubMed ID: 30586400 [TBL] [Abstract][Full Text] [Related]
11. Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study. Al-Jedai A; Almudaiheem H; Al-Salamah T; Aldosari M; Almutairi AR; Almogbel Y; AlRuthia Y; Althemery AU; Alluhidan M; Roudijk B; Purba FD; Awad N; O'jeil R Value Health; 2024 May; 27(5):552-561. PubMed ID: 38342365 [TBL] [Abstract][Full Text] [Related]
12. EQ-5D-5L Valuation for the Malaysian Population. Shafie AA; Vasan Thakumar A; Lim CJ; Luo N; Rand-Hendriksen K; Md Yusof FA Pharmacoeconomics; 2019 May; 37(5):715-725. PubMed ID: 30535779 [TBL] [Abstract][Full Text] [Related]
13. Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945 [TBL] [Abstract][Full Text] [Related]
14. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values. Fitriana TS; Roudijk B; Purba FD; Busschbach JJV; Stolk E Pharmacoeconomics; 2022 Dec; 40(Suppl 2):157-167. PubMed ID: 36348155 [TBL] [Abstract][Full Text] [Related]
16. Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data. Ramos-Goñi JM; Oppe M; Estévez-Carrillo A; Rivero-Arias O; Value Health; 2022 May; 25(5):835-843. PubMed ID: 35500952 [TBL] [Abstract][Full Text] [Related]
17. An EQ-5D-5L Value Set for Vietnam. Mai VQ; Sun S; Minh HV; Luo N; Giang KB; Lindholm L; Sahlen KG Qual Life Res; 2020 Jul; 29(7):1923-1933. PubMed ID: 32221805 [TBL] [Abstract][Full Text] [Related]
18. EQ-5D-5L: a value set for Romania. Olariu E; Mohammed W; Oluboyede Y; Caplescu R; Niculescu-Aron IG; Paveliu MS; Vale L Eur J Health Econ; 2023 Apr; 24(3):399-412. PubMed ID: 35688994 [TBL] [Abstract][Full Text] [Related]
19. Estimating the EQ-5D-5L value set for the Philippines. Miguel RTD; Rivera AS; Cheng KJG; Rand K; Purba FD; Luo N; Zarsuelo MA; Genuino-Marfori AJ; Florentino-Fariñas I; Guerrero AM; Lam HY Qual Life Res; 2022 Sep; 31(9):2763-2774. PubMed ID: 35532835 [TBL] [Abstract][Full Text] [Related]
20. Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study. Ludwig K; von der Schulenburg JG; Greiner W Health Qual Life Outcomes; 2017 Feb; 15(1):39. PubMed ID: 28219389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]